(Senior) Project Leader Biochemical Development - Batterman Consulting
Project management of the feasibility studies with responsibility for costs, milestones and regulatory requirements
Creating the concept and setting up the in-vivo feasibility studies for the area of gene therapies
Designing the necessary experiments for data collection and presenting the data and project progress to internal and external stakeholders
Coordination of the internal development and production of the hemosorbents
Project management for the hardware and software development of a prototype for the in-vivo studies
Coordination of CRO for the cost-efficient and timely implementation of the studies
Ensuring comprehensive documentation of all development steps
Your profile
Completed studies (Master/PhD) in virology, immunology or equivalent, ideally with experience in the field of AAV / gene therapies
At least 5 years of industry experience in the pharmaceutical or medical device industry
Very good project management skills and experience in managing in-vivo studies in collaboration with CROs
Very good communication and presentation skills, organized and structured way of working
Ability to work cross-functionally and interact with internal and external stakeholders, preferably with experience in/with larger pharmaceutical companies
Business fluent in English, knowledge of German is an advantage
Your benefits
A unique opportunity to be part of bringing a live-saving therapy to the market that will change the medical landscape.
A dynamic work environment in an award-winning and highly motivated start-up team, with flat hierarchies and lots of room for self-realization and implementation of your ideas
An exciting and modern workplace at Bio-Technopark Schlieren, 20 min from Zurich HB by public transport
Up to 2 days of remote work per week
Our client
Hemotune AG is a Swiss medical technology start-up company that emerged from ETH Zurich. The goal is to develop a life-saving, groundbreaking medical product for targeted blood purification. The company, based in Schlieren / ZH, is currently in the preclinical development phase. It is also working on expanding the field of application to new indications. To make this step a success, the team in Biochemical Development will be further expanded. Place of work: Schlieren